CO-DIAGNOSTICS INC (CODX)

Company Profile

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company is headquartered in Salt Lake City, Utah and currently employs 145 full-time employees. The company went IPO on 2017-07-12. The firm is engaged in developing, manufacturing and selling reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, including molecular tools for the detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also uses its technology to design specific tests for its Co-Dx PCR Home platform and to locate genetic markers for use in applications other than infectious disease. The company also sells diagnostic equipment from other manufacturers as self-contained lab systems. The firm is also developing a portable polymerase chain reaction (PCR) device and test cups that are designed to bring PCR to patients in point-of-care and even at-home settings. Its diagnostics systems enable molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.

Company Info

CO-DIAGNOSTICS INC

4049 S Highland Dr

Salt Lake City UTAH 84109

P: 18012789769

CEO: Dwight Egan

Employees: 145

Website: http://codiagnostics.com/